"REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY" is publishing soon a Special Volume about Liver SBRT. It is edited by Drs M.Macià and C. Llacer-Moscardó.

We share the volume Index, where you can see the different articles, where great specialists in the matter have participated.

pdfSpecial Issue: 21 Liver SBRT121.55 KB

Biomarkers Under the 4th International Workshop on the treatment of liver and lung metastases in colorectal cancer, organized by the Hospital Universitari Mutua Terrassa, University of Barcelona, ​​has occurred Panitumumab symposium: the value of personalized medicine Amgen and in which participated Dr. Eduardo Diaz-Rubio, head of Medical Oncology University Hospital Clinico San Carlos, Madrid, Dr. Jean-Yves Douillard, the Institut de l'ouest Cancérologie (ICO) René Gauducheu, Nantes, France and Dr. Cristina Nadal Hospital Clínic of Barcelona. During the symposium the results of the PRIME study published in the New England Journal of Medicine on biomarker RAS mutational status, by Dr. Jean-Yves Douillard, first author of the paper were presented. According Douillard, the study shows that "in a patient with metastatic colorectal cancer, the probability that the biomarker is mutated RAS is 50-50".


The diocesan seminary Monte Corban Santander hosted the week of July 28 to 31, the the Medicine course Innovation in oncology. The challenge of functional units, organized by the Catholic University of Valencia "San Vicente Mártir" and the Therapeutic Association in Hematology and Medical Oncology, Hospital Arnau de Vilanova.

During the course fifteen oncologists, pathologists, radiologists, surgeons, psychologists and nurses, who analyzed the advances in detection and early treatment of cancer, considered the leading cause of death in the population under 75 years were cited.

These experts shared care solutions both as resource management, research and training that have enabled significant improvements in survival over the past two decades and the challenges that patients, doctors and managers face today. The sessions, aimed at professionals, with room for both specialists in training as medical students and nurses, were divided according to functional management units tumor pathology, originally driven by the "Comprehensive Cancer Centers" in the United States, where specialists from different areas come together in the treatment of a specific carcinogenic pathology in order to offer the best treatment option individually.

The sessions, led by professor of oncology at VCU and Head of Service in the Hospital Arnau de Vilanova, Dr. Antonio Llombart, focused on units in the breast, lung, digestive and continuing care.

Further information: Catholic University of Valencia